Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore W Randolph

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
Biochemistry|January 22, 2003
Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesisSampathkumar Krishnan, Eva Y Chi, Stephen J Wood, et al.
Journal of Pharmaceutical Sciences|January 13, 2015
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvantsKimberly J Hassett, David J Vance, Nishant K Jain, et al.
Iscience|October 27, 2025
Broad anti-sarbecovirus responses elicited by a single administration of mosaic-8 RBD-nanoparticle vaccine prepared using atomic layer depositionAlexander A Cohen, Jennifer R Keeffe, Annie V Rorick, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Single administration of mosaic-8b RBD-nanoparticle vaccine prepared with atomic layer deposition technology elicits broadly neutralizing anti-sarbecovirus responsesAlexander A Cohen, Jennifer R Keeffe, Annie V Rorick, et al.
Vaccine|August 17, 2021
Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvantKendall B Preston, Teri Ann S Wong, Albert To, et al.
Journal of Pharmaceutical Sciences|August 16, 2008
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product qualityJohn F Carpenter, Theodore W Randolph, Wim Jiskoot, et al.
Journal of Pharmaceutical Sciences|May 24, 2022
Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80-Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human PrimatesKendall B Preston, Teri Ann S Wong, Michael M Lieberman, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery to lymph nodes enhance humoral immune responsesNamit Chaudhary, Holly J Coleman, Elias V Paolone, et al.
Journal of Pharmaceutical Sciences|November 22, 2021
An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle DispersionKurt D Benkstein, Gurusamy Balakrishnan, Ashwinkumar Bhirde, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Biochemistry|January 22, 2003
Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesisSampathkumar Krishnan, Eva Y Chi, Stephen J Wood, et al.
Journal of Pharmaceutical Sciences|January 13, 2015
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvantsKimberly J Hassett, David J Vance, Nishant K Jain, et al.
Iscience|October 27, 2025
Broad anti-sarbecovirus responses elicited by a single administration of mosaic-8 RBD-nanoparticle vaccine prepared using atomic layer depositionAlexander A Cohen, Jennifer R Keeffe, Annie V Rorick, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Single administration of mosaic-8b RBD-nanoparticle vaccine prepared with atomic layer deposition technology elicits broadly neutralizing anti-sarbecovirus responsesAlexander A Cohen, Jennifer R Keeffe, Annie V Rorick, et al.
Vaccine|August 17, 2021
Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvantKendall B Preston, Teri Ann S Wong, Albert To, et al.
Journal of Pharmaceutical Sciences|August 16, 2008
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product qualityJohn F Carpenter, Theodore W Randolph, Wim Jiskoot, et al.
Journal of Pharmaceutical Sciences|May 24, 2022
Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80-Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human PrimatesKendall B Preston, Teri Ann S Wong, Michael M Lieberman, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery to lymph nodes enhance humoral immune responsesNamit Chaudhary, Holly J Coleman, Elias V Paolone, et al.
Journal of Pharmaceutical Sciences|November 22, 2021
An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle DispersionKurt D Benkstein, Gurusamy Balakrishnan, Ashwinkumar Bhirde, et al.
Pageof 18